CloudLIMS

Executive Summary

CloudLIMS is a US-based provider of a cloud-native Laboratory Information Management System (LIMS) delivered as a SaaS platform. Founded in 2012 and headquartered in Wilmington, Delaware, the company serves diverse laboratory verticals including biobanking, clinical diagnostics, cannabis testing, genomics, and environmental testing. Its solution enables labs to digitize operations, manage complex sample workflows, ensure regulatory compliance (e.g., CLIA, CAP, ISO 15189), and improve data integrity. As laboratories increasingly adopt digital transformation to reduce manual errors and meet stringent quality standards, CloudLIMS is well-positioned to capture market share in the growing LIMS market, estimated to reach $4.5 billion by 2028. The company’s cloud-native architecture offers scalability, lower IT overhead, and remote access, which are key differentiators against legacy on-premise competitors. While CloudLIMS remains privately held and has not disclosed funding rounds, its sustained presence over a decade suggests a loyal customer base and recurring revenue stream. In the coming quarters, the company is expected to focus on expanding its AI-driven analytics module, deepening integrations with lab instruments, and targeting high-growth segments such as cannabis testing, where regulatory pressures are driving LIMS adoption. However, competition from larger vendors and the need for continuous innovation present ongoing challenges.

Upcoming Catalysts (preview)

• Q3 2026Launch of AI-Powered Sample Tracking and Predictive Analytics Module70% success
• Q4 2026Strategic Partnership with Major Diagnostic Laboratory Chain50% success
• Q2 2026ISO 27001 Certification for Enhanced Data Security85% success